Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
14,365,152
-
Total 13F shares
-
678,595
-
Share change
-
+678,595
-
Total reported value
-
$2,721,066
-
Price per share
-
$4.01
-
Number of holders
-
13
-
Value change
-
+$2,721,065
-
Number of buys
-
12
Institutional Holders of CalciMedica, Inc. - Common (CALC) as of Q2 2023
As of 30 Jun 2023,
CalciMedica, Inc. - Common (CALC) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
678,595 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BML Capital Management, LLC, FIRST MANHATTAN CO. LLC., MERITAGE PORTFOLIO MANAGEMENT, Tower Research Capital LLC (TRC), MORGAN STANLEY, NewEdge Advisors, LLC, WELLS FARGO & COMPANY/MN, and UBS Group AG.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.